Cited by — Clinico-genomic risk stratification for biomarker-enriched trial design in poor-prognosis metastatic castrate-resistant prostate cancer (mCRPC) | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Clinico-genomic risk stratification for biomarker-enriched trial design in poor-prognosis metastatic castrate-resistant prostate cancer (mCRPC).
No admitted local citation edges point to this work yet.
